AirSculpt Technologies, Inc. (AIRS) Current Ratio
- Current ratio · latest quarter: Value 0.79×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.79× | Current assets / current liabilities. $27.50M ÷ $34.95M ≈ 0.79× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 27.50M USD | Assets, Current |
| Current obligations | 34.95M USD | Liabilities, Current |
| Cash and equivalents | 18.82M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 7.26M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 10.46M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.50M | $34.95M | $18.82M | (m) | (m) | (m) | $7.26M | $10.46M | 0.79× |
| 2026-03-31 | $24.33M | $32.48M | $16.69M | (m) | (m) | (m) | $7.46M | $5.46M | 0.75× |
| 2025-12-31 | $15.46M | $27.90M | $8.45M | (m) | (m) | (m) | $5.37M | $5.46M | 0.55× |
| 2025-09-30 | $12.22M | $24.16M | $5.41M | (m) | (m) | (m) | $4.46M | $5.00M | 0.51× |
| 2025-06-30 | $16.41M | $25.83M | $8.19M | (m) | (m) | (m) | $3.34M | $4.55M | 0.64× |
| 2025-03-31 | $15.30M | $26.79M | $5.55M | (m) | (m) | (m) | $4.14M | $4.25M | 0.57× |
| 2024-12-31 | $17.12M | $28.95M | $8.23M | (m) | (m) | (m) | $6.26M | $4.25M | 0.59× |
| 2024-09-30 | $12.89M | $25.35M | $5.97M | (m) | (m) | (m) | $6.79M | $3.72M | 0.51× |
| 2024-06-30 | $21.69M | $25.12M | $9.87M | (m) | (m) | (m) | $4.56M | $3.19M | 0.86× |
| 2024-03-31 | $14.99M | $21.77M | $10.97M | (m) | (m) | (m) | $4.32M | $2.66M | 0.69× |
| 2023-12-31 | $15.96M | $20.32M | $10.26M | (m) | (m) | (m) | $3.92M | $2.13M | 0.79× |
| 2023-09-30 | $16.41M | $19.79M | $8.66M | (m) | (m) | (m) | $3.56M | $2.13M | 0.83× |
| 2023-06-30 | $26.83M | $23.95M | $20.78M | (m) | (m) | (m) | $4.18M | $2.13M | 1.12× |
| 2023-03-31 | $17.89M | $21.52M | $11.28M | (m) | (m) | (m) | $4.34M | $2.13M | 0.83× |
| 2022-12-31 | $16.68M | $22.32M | $9.62M | (m) | (m) | (m) | $3.84M | $2.13M | 0.75× |
| 2022-09-30 | $9.74M | $13.55M | $7.60M | (m) | (m) | (m) | $3.09M | $850.00K | 0.72× |
| 2022-06-30 | $38.71M | $17.27M | $35.25M | (m) | (m) | (m) | $4.69M | $850.00K | 2.24× |
| 2022-03-31 | $32.36M | $15.91M | $27.23M | (m) | (m) | (m) | $3.39M | $850.00K | 2.03× |
| 2021-12-31 | $29.44M | $16.41M | $25.35M | (m) | (m) | (m) | $2.67M | $850.00K | 1.79× |
| 2020-12-31 | $11.56M | $9.46M | $10.38M | (m) | (m) | (m) | $1.09M | $400.00K | 1.22× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |